FDA recently requested additional information to evaluate whether a REMS is necessary for mitapivat in sickle cell diseaseFDA classified Agios’ ...
Between 2010 and 2024, medical spending in the US grew from 17.2 percent of GDP to 18.0 percent. This growth was ...
On October 20, 2026, the Food and Drug Administration (FDA) announced final guidance titled Regulatory Considerations for Prescription ...
GoodRx reports on 10 common issues that can delay prescription refills and offers solutions, emphasizing the importance of ...
A mixed-methods study of 30 Spanish-preferred adults with limited English proficiency found that only 23% had received a ...
FDA finalized guidance on apps paired with prescription drugs, from inhaler trackers to dose reminders. Here is what it means ...
The US Food and Drug Administration (FDA) on Tuesday finalized guidance to address how sponsors can develop, distribute, and ...
The FDA is codifying its regulations around mobile apps that go along with prescription drugs, offering a clearer framework ...
The US FDA on Tuesday issued guidance aimed at clarifying how drug companies ​can develop, distribute and label apps used ‌alongside their prescription medicines.
FDA finalized guidance setting out how drug sponsors should label, describe and submit content from software used alongside ...
What prescription hair-removal cream actually does Prescription hair-removal cream containing eflornithine does not remove ...
Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results